David R. Wood

European psychiatry · with Dekker · 2001–2009

A researcher in the Science corpus: 2 papers; trusts 0 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Who trusts David R. Wood overall

  1. I. Graham
  2. S. Feasson
  3. AndrewJ. S. Coats

Papers from David R. Wood's perspective

Ordered by how strongly the researchers David R. Wood trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Physical health monitoring of patients with schizophrenia. (American Journal of Psychiatry)
  2. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. (Schizophrenia Research)
  3. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. (New England Journal of Medicine)
  4. Schizophrenia and increased risks of cardiovascular disease. (American Heart Journal)
  5. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. (New England Journal of Medicine)
  6. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Rsearch Database. (Archives of General Psychiatry)
  7. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. (New England Journal of Medicine)
  8. Second-Generation (Atypical) Antipsychotics and Metabolic Effects (CNS Drugs)
  9. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. (The Lancet)
  10. Metabolic syndrome in people with schizophrenia: a review (World Psychiatry)

Their papers